Germ-line BRCA2 (MIM# 600185) mutations in female carriers confer a lifetime risk exceeding 80% for breast cancer and 20% for ovarian cancer, and a moderate increased risk of other cancer types [1,2]. Here, BRCA2 is linked to ovarian cancer.